The Role of HDACs Inhibitors in Childhood and Adolescence Acute Leukemias
Acute leukemia is the most common type of childhood and adolescence cancer, characterized by clonal proliferation of variably differentiated myeloid or lymphoid precursors. Recent insights into the molecular pathogenesis of leukemia have shown that epigenetic modifications, such as deacetylation of...
Main Authors: | Riccardo Masetti, Salvatore Serravalle, Carlotta Biagi, Andrea Pession |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2011-01-01
|
Series: | Journal of Biomedicine and Biotechnology |
Online Access: | http://dx.doi.org/10.1155/2011/148046 |
Similar Items
-
First-line treatment of acute lymphoblastic leukemia with pegasparaginase
by: Riccardo Masetti, et al.
Published: (2009-07-01) -
Use of clofarabine for acute childhood leukemia
by: A Pession, et al.
Published: (2010-06-01) -
Acute myeloid leukemia in infants: biology and treatment
by: Riccardo eMasetti, et al.
Published: (2015-04-01) -
Insights on the Interplay between Cells Metabolism and Signaling: A Therapeutic Perspective in Pediatric Acute Leukemias
by: Laura Anselmi, et al.
Published: (2020-08-01) -
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells.
by: Michele Cea, et al.
Published: (2011-01-01)